Literature DB >> 21287438

[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management].

P Layer1, V Andresen, C Pehl, H Allescher, S C Bischoff, M Classen, P Enck, T Frieling, S Haag, G Holtmann, M Karaus, S Kathemann, J Keller, R Kuhlbusch-Zicklam, W Kruis, J Langhorst, H Matthes, H Mönnikes, S Müller-Lissner, F Musial, B Otto, C Rosenberger, M Schemann, I van der Voort, K Dathe, J C Preiss.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21287438     DOI： 10.1055/s-0029-1245976

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN： 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  44 in total

1.  Irritable bowel syndrome--the main recommendations.

Authors:  Viola Andresen; Jutta Keller; Christian Pehl; Michael Schemann; Jan Preiss; Peter Layer
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Many causes are unknown.

Authors:  Christoph Namislo
Journal:  Dtsch Arztebl Int       Date:  2012-02-10       Impact factor: 5.594

Review 3.  [Visceral pain].

Authors:  S Elsenbruch; W Häuser; W Jänig
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

4.  Functional bowel disorders in adults.

Authors:  Winfried Häuser; Peter Layer; Peter Henningsen; Wolfgang Kruis
Journal:  Dtsch Arztebl Int       Date:  2012-02-03       Impact factor: 5.594

5.  [Somatoform disorders: discussion on conceptual and diagnostic issues].

Authors:  C Hausteiner-Wiehle; P Henningsen
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

Review 6.  [Psychophysiology of visceral pain].

Authors:  B Horing; P Enck
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 7.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

8.  Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.

Authors:  Mark Fisher; Andrew Walker; Meritxell Falqués; Miguel Moya; Mark Rance; Douglas Taylor; Leandro Lindner
Journal:  Eur J Health Econ       Date:  2016-01-04

Review 9.  [Pain therapy in irritable bowel syndrome].

Authors:  M de Greck; P Layer; V Andresen
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

10.  Non-specific, functional, and somatoform bodily complaints.

Authors:  Rainer Schaefert; Constanze Hausteiner-Wiehle; Winfried Häuser; Joram Ronel; Markus Herrmann; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.